Use of cell-free circulating RNA and expression of PD-L1 and HER2 in plasma to monitor and predict clinical response in metastatic breast cancer patients

被引：0
|
作者：
Castrellon, Aurelio B.
Velez, Michel
Raez, Luis E.
Danenberg, Kathleen
Rabizadeh, Shahrooz
Usher, Joshua
Jaimes, Yolanda
Hunis, Brian
Bittencourt, Ana C.
Milillo, Adriana
Blaya, Marcelo
Habaue, Cheryl
Danenberg, Peter V.
机构：
[1] Mem Canc Inst, Hollywood, FL USA
[2] Liquid Genom Inc, Culver City, CA USA
[3] NantOmics, Culver City, CA USA
[4] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-02-16
引用
收藏
页数：1
相关论文
共 50 条
  • [21] MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Breast Cancer Patients
    Maniaci, Joseph
    Mills, Anne
    Dillon, Patrick
    Gaughan, Elizabeth
    Jenkins, Taylor
    LABORATORY INVESTIGATION, 2022, 102 (SUPPL 1) : 160 - 161
  • [22] PD-L1 and HER2 Expression in Gastroesophageal Cancer: a Matched Case Control Study
    Beer, Andrea
    Taghizadeh, Hossein
    Schiefer, Ana-Iris
    Puhr, Hannah C.
    Karner, Alexander K.
    Jomrich, Gerd
    Schoppmann, Sebastian F.
    Kain, Renate
    Preusser, Matthias
    Ilhan-Mutlu, Ayseguel
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (04) : 2225 - 2235
  • [23] MHC Class I and PD-L1 Expression May Predict Treatment Response to Anti-PD-1/PD-L1 Therapy in Breast Cancer Patients
    Maniaci, Joseph
    Mills, Anne
    Dillon, Patrick
    Gaughan, Elizabeth
    Jenkins, Taylor
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 160 - 161
  • [24] Clinical Use of HER2 Extracellular Domain as a Marker to Monitor Cancer Status and Predict the Response to Anti-cancer Treatment in Breast Cancer
    Kontani, K.
    Hashimoto, S.
    Murazawa, C.
    Ohtani, M.
    Date, M.
    Yamauchi, A.
    Yokomise, H.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S274 - S274
  • [25] PD-L1 Gene Expression and Total Cell-Free RNA Measured in Blood Positively Differentiate Healthy Individuals from Metastatic NSCLC Patients
    Danenberg, Kathleen
    Hoffmann, Andreas-Claudius
    Danenberg, Peter V.
    Usher, Joshua
    Li, Jin
    Elshimali, Yahya
    Huang, Xu
    Dang, Mai
    Sturdevant, Todd
    Jaimes, Yolanda
    Findlater, Robert
    Grino, Mary
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S601 - S602
  • [26] PD-L1 expression on circulating tumor cells and prognosis of breast cancer patients.
    Wang, Xuefei
    Zhang, Goechao
    Sun, Qiang
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Assessment of PD-L1 expression in circulating tumor cells in patients with breast cancer.
    Chen, Junqing
    Chen, Zhanhong
    Wang, Xiaojia
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
    Qui, Shi
    Takeshita, Takashi
    Sueta, Aiko
    Tomiguchi, Mai
    Goto-Yamaguchi, Lisa
    Hidaka, Kaori
    Suzu, Ikuko
    Yamamoto, Yutaka
    Iwase, Hirotaka
    BREAST CANCER, 2021, 28 (03) : 746 - 754
  • [29] Analysis of plasma HER2 copy number in cell-free DNA of breast cancer patients: a comparison with HER2 extracellular domain protein level in serum
    Shi Qui
    Takashi Takeshita
    Aiko Sueta
    Mai Tomiguchi
    Lisa Goto-Yamaguchi
    Kaori Hidaka
    Ikuko Suzu
    Yutaka Yamamoto
    Hirotaka Iwase
    Breast Cancer, 2021, 28 : 746 - 754
  • [30] Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?
    Fabi, A
    Ferretti, G
    Salesi, N
    Papaldo, P
    Carlini, P
    Ciccarese, M
    Di Cocco, B
    Cecere, F
    Nardoni, C
    Felici, A
    Cognetti, F
    ANNALS OF ONCOLOGY, 2005, 16 (03) : 516 - 517
12345